EDITAS MEDICINE INC.
3.2800
06-November-24 14:59:58
15 minutes delayed
Stocks
+0.1600
+5.13%
Today's range
3.0601 - 3.4000
ISIN
N/A
Source
NASDAQ
-
25 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Upcoming Investor Events
30 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Second Quarter 2023 Results and Business Updates
02 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
27 Jul 2023 08:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Second Quarter 2023 Results Conference Call and Corporate Update
26 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Pricing of Offering of Common Stock
14 Jun 2023 21:06:40 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Offering of Common Stock
14 Jun 2023 15:05:00 By Nasdaq GlobeNewswire
-
Editas Medicine Reports Inducement Grant to New Chief Financial Officer
18 May 2023 15:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Appointment of Erick J. Lucera as Chief Financial Officer
16 May 2023 15:30:00 By Nasdaq GlobeNewswire
-
11 May 2023 09:32:40 By Nasdaq GlobeNewswire
-
Editas Medicine Announces First Quarter 2023 Results and Business Updates
05 May 2023 06:00:00 By Nasdaq GlobeNewswire
-
01 May 2023 15:01:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces First Quarter 2023 Results Conference Call and Upcoming Investor Events
01 May 2023 05:45:00 By Nasdaq GlobeNewswire
-
27 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Strengthens Board of Directors with Appointment of New Chair and New Director
13 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
08 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Fourth Quarter and Full Year 2022 Results and Business Updates
22 Feb 2023 05:15:00 By Nasdaq GlobeNewswire
-
15 Feb 2023 05:45:00 By Nasdaq GlobeNewswire